OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advancements in CRISPR screens for the development of cancer immunotherapy strategies
Yan-Ruide Li, Zibai Lyu, Yanxin Tian, et al.
Molecular Therapy — Oncolytics (2023) Vol. 31, pp. 100733-100733
Open Access | Times Cited: 9
Yan-Ruide Li, Zibai Lyu, Yanxin Tian, et al.
Molecular Therapy — Oncolytics (2023) Vol. 31, pp. 100733-100733
Open Access | Times Cited: 9
Showing 9 citing articles:
A functional single-cell metabolic survey identifies Elovl1 as a target to enhance CD8+ T cell fitness in solid tumours
Samantha Pretto, Qian Yu, Pierre Bourdely, et al.
Nature Metabolism (2025)
Open Access | Times Cited: 1
Samantha Pretto, Qian Yu, Pierre Bourdely, et al.
Nature Metabolism (2025)
Open Access | Times Cited: 1
Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review
Paulina J. Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 705-705
Open Access | Times Cited: 5
Paulina J. Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 705-705
Open Access | Times Cited: 5
Transforming cancer treatment: integrating patient-derived organoids and CRISPR screening for precision medicine
Ziyi Zhu, John Paul Shen, Paul Chi-Lui Ho, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Ziyi Zhu, John Paul Shen, Paul Chi-Lui Ho, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Computational modeling of metabolism in oncology
Linda Fong, Meng Jin, Samir Kharbanda, et al.
Elsevier eBooks (2025), pp. 81-107
Closed Access
Linda Fong, Meng Jin, Samir Kharbanda, et al.
Elsevier eBooks (2025), pp. 81-107
Closed Access
Overcoming Resistance Mechanisms to Melanoma Immunotherapy
David X. Zheng, David J. Bozym, Giuseppe Tarantino, et al.
American Journal of Clinical Dermatology (2024)
Closed Access | Times Cited: 2
David X. Zheng, David J. Bozym, Giuseppe Tarantino, et al.
American Journal of Clinical Dermatology (2024)
Closed Access | Times Cited: 2
Strategies and delivery systems for cell-based therapy in autoimmunity
Matteo Puccetti, Claudio Costantini, Aurélie Schoubben, et al.
Frontiers in Drug Delivery (2024) Vol. 4
Open Access
Matteo Puccetti, Claudio Costantini, Aurélie Schoubben, et al.
Frontiers in Drug Delivery (2024) Vol. 4
Open Access
Recent progress in CRISPR-Cas-system for neurological disorders
Sarita Mishra, Shuvomoy Banerjee, Budhi Sagar Tiwari, et al.
Progress in molecular biology and translational science (2024), pp. 231-261
Closed Access
Sarita Mishra, Shuvomoy Banerjee, Budhi Sagar Tiwari, et al.
Progress in molecular biology and translational science (2024), pp. 231-261
Closed Access
Developing pioneering pharmacological strategies with CRISPR/Cas9 library screening to overcome cancer drug resistance
Yu He, Huan Li, Xueming Ju, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189212-189212
Closed Access
Yu He, Huan Li, Xueming Ju, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189212-189212
Closed Access
Clinical Applications, Patents, and Challenges in Cancer Immunotherapy
Ashirbad Nanda, Satish Kanhar, Mandeep Kumar Singh, et al.
(2024), pp. 471-492
Closed Access
Ashirbad Nanda, Satish Kanhar, Mandeep Kumar Singh, et al.
(2024), pp. 471-492
Closed Access
